FCGR1A and Miyoshi myopathy: A dysregulated functional capacity of myeloid cells in MM patients, including decreased capacity for phagocytosis and oxidative burst associated with elevated neutrophil CD64 levels, increased STAT3 phosphorylation, and immunosuppressive properties, has been previously reported (9).